Lv11
30 积分 2026-02-05 加入
Individualized neoantigen therapy mRNA-4157 (V940) plus pembrolizumab in resected melanoma: 3-year update from the mRNA-4157-P201 (KEYNOTE-942) trial
5小时前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
5小时前
已完结
Identification and Preclinical Evaluation of a Novel GD2 Antibody-Drug Conjugate for Solid Tumors in Children and Adults
1个月前
已完结
Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
2个月前
已完结
A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
3个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
3个月前
已完结
Intestinal pH: a major driver of human gut microbiota composition and metabolism
3个月前
已完结
Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo
3个月前
已完结
The immunology of vitiligo
3个月前
已完结
Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo
3个月前
已完结
皖公网安备34019202002308
